5 Key Takeaways

• 1

  A urine-based DNA test can identify patients with hematuria who need urgent cystoscopy, allowing lower-risk patients to delay the procedure.

• 2

  The GALEAS Bladder assay detected 71 of 77 bladder cancers and had a negative predictive value exceeding 99 percent.

• 3

  The study involved 964 participants, with 77 confirmed cases of bladder cancer, highlighting the assay's diagnostic capabilities.

• 4

  Using the urine test could reduce immediate cystoscopies by 730 per 1000 patients without compromising overall clinical benefit.

• 5

  The study indicates a potential role for molecular testing as a triage tool, but randomized evidence is needed for broader recommendations.